Molecular Profiles has expanded capabilities at its UK production site to extend its analytical and formulation support to Phase IIa.
Nikin Patel, CEO of Molecular Profiles, said: “The expansion of our service offering greatly reduces the need for technical transfer and ensures products get developed in time”. Molecular Profiles has expertise in poorly soluble and potent drugs and can now apply this up to Phase IIa.
Services offered by Molecular Profiles include: formulation development; pre-formulation; polymorph screening; salt selection; analytical services; and clinical trial manufacturing. Molecular Profiles provides these services from its manufacturing site in Nottingham, UK.